Menu

Chronic venous
insufficiency

Venous reflux is a progressive condition that if left untreated can lead to chronic venous insufficiency (CVI).

 

More on CVI

VenaSeal™
closure system

Reach new lengths. Treat more diseased vein — maximize your impact. The VenaSeal™ closure system delivers immediate and lasting vein closure with its proprietary medical adhesive formula, with a demonstrated 94.6% closure rate at 5 years.1-5

 

Learn more

ClosureFast™
procedure

The ClosureFast procedure, with its patented overlap design, is the only RFA procedure with published clinical data demonstrating long-term safety and efficacy, with a 91.9% closure rate at 5 years.4,5

 

View procedure

Clinical evidence

See clinical evidence for our superficial vein therapy products.

See evidence

Resources and support

Find product, condition, and patient education materials.

Find resources

Connect with us

Connect with a Medtronic representative and sign up for ongoing updates.
 

Products

Filter by
  1. Morrison N, Gibson K, McEnroe S, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015;61(4):985-994.
  2. Proebstle T, Alm J, Dimitri S, et al. Three-year follow-up results of the prospective European Multicenter Cohort Study on Cyanoacrylate Embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2021;9(2):329-334.
  3. Gibson K, Ferris B. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: Initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular. 2017;25(2):149-156.
  4. Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Thirty-sixth month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. 2017;5(5):658-666.
  5. Morrison N, Gibson K, Vasquez M, Weiss R, Jones A. Five-year extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2020;8(6):978-989.